Immune Regulatory Function of Cancer- Associated Fibroblasts in Non-small Cell Lung Cancer

Overview

Journal Tuberc Respir Dis (Seoul)

Specialty Pulmonary Medicine

Date 2023 Jun 22

PMID 37345462

Authors

Hyewon Lee

Mina Hwang

Seonae Jang

Sang-Won Um

Affiliations

Soon will be listed here.

Abstract

Background: Cancer-associated fibroblasts (CAFs) are key components of the tumor microenvironment and significantly contribute to immune evasion. We investigated the effects of CAFs on the immune function of CD4+ and CD8+ T cells in non-small cell lung cancer (NSCLC).

Methods: We isolated CAFs and normal fibroblasts (NFs) from tumors and normal lung tissues of NSCLC patients, respectively. CAFs were co-cultured with activated T cells to evaluate their immune regulatory function. We investigated the effect of CAF conditioned medium (CAF-CM) on the cytotoxicity of T cells. CAFs were also co-cultured with activated peripheral blood mononuclear cells and further incubated with cyclooxygenase- 2 (COX2) inhibitors to investigate the potential role of COX2 in immune evasion.

Results: CAFs and NFs were isolated from the lung tissues (n=8) and lymph nodes (n=3) of NSCLC patients. Immune suppressive markers, such as COX2 and programmed death-ligand 1 (PD-L1), were increased in CAFs after co-culture with activated T cells. Interestingly, CAFs promoted the expression of programmed death-1 in CD4+ and CD8+ T cells, and strongly inhibited T cell proliferation in allogenic and autologous pairs of CAFs and T cells. CAF-CM decreased the cytotoxicity of T cells. COX2 inhibitors partially restored the proliferation of CD4+ and CD8+ T cells, and downregulated the expression of COX2, prostaglandin E synthase, prostaglandin E2, and PD-L1 in CAFs.

Conclusion: CAFs promote immune evasion by suppressing the function of CD4+ and CD8+ T cells via their effects on COX2 and PD-L1 in NSCLC. The immunosuppressive function of CAFs could be alleviated by COX2 inhibitors.

Citing Articles

Development and application of a predictive model for survival and drug therapy based on COVID-19-related lncRNAs in non-small cell lung cancer.

Huang Z, Han Z, Zheng K, Zhang Y, Liang Y, Zhu X Medicine (Baltimore). 2024; 103(49):e40629.

PMID: 39654255 PMC: 11631024. DOI: 10.1097/MD.0000000000040629.

The Clinical Significance of Cancer-Associated Fibroblasts Classification in Non-Small Cell Lung Cancer.

Papavassiliou K, Sofianidi A, Gogou V, Papavassiliou A Cells. 2024; 13(22).

PMID: 39594657 PMC: 11592919. DOI: 10.3390/cells13221909.

References

Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S . Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 1998; 58(17):3761-4. View

Ogino S, Kirkner G, Nosho K, Irahara N, Kure S, Shima K . Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin Cancer Res. 2008; 14(24):8221-7. PMC: 2679582. DOI: 10.1158/1078-0432.CCR-08-1841. View

Zhang J, Zou F, Tang J, Zhang Q, Gong Y, Wang Q . Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor. Circ Res. 2013; 113(2):104-14. PMC: 4219358. DOI: 10.1161/CIRCRESAHA.113.301033. View

Klein J, Sato A . The HLA system. First of two parts. N Engl J Med. 2000; 343(10):702-9. DOI: 10.1056/NEJM200009073431006. View

DuBois R . Role of inflammation and inflammatory mediators in colorectal cancer. Trans Am Clin Climatol Assoc. 2014; 125:358-72. PMC: 4112706. View

Kalluri R . The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016; 16(9):582-98. DOI: 10.1038/nrc.2016.73. View

Su S, Ho H, Li J, Wu M, Wang H, Yeh H . DNA methylome and transcriptome landscapes of cancer-associated fibroblasts reveal a smoking-associated malignancy index. J Clin Invest. 2021; 131(16). PMC: 8363271. DOI: 10.1172/JCI139552. View

Chen J, Li C, Kuo C, Tsai K, Hou M, Hung W . Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression. Breast Cancer Res. 2014; 16(4):410. PMC: 4220086. DOI: 10.1186/s13058-014-0410-1. View

Markosyan N, Chen E, Evans R, Ndong V, Vonderheide R, Smyth E . Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity. Breast Cancer Res. 2013; 15(5):R75. PMC: 3979159. DOI: 10.1186/bcr3469. View

10.

Tlsty T, Coussens L . Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2007; 1:119-50. DOI: 10.1146/annurev.pathol.1.110304.100224. View

11.

Eberhart C, Coffey R, Radhika A, Giardiello F, Ferrenbach S, DuBois R . Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994; 107(4):1183-8. DOI: 10.1016/0016-5085(94)90246-1. View

12.

Sato N, Maehara N, Goggins M . Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts. Cancer Res. 2004; 64(19):6950-6. DOI: 10.1158/0008-5472.CAN-04-0677. View

13.

Hoshino A, Ishii G, Ito T, Aoyagi K, Ohtaki Y, Nagai K . Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression. Cancer Res. 2011; 71(14):4769-79. DOI: 10.1158/0008-5472.CAN-10-3228. View

14.

Nordby Y, Richardsen E, Rakaee M, Ness N, Donnem T, Patel H . High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Sci Rep. 2017; 7:43378. PMC: 5324133. DOI: 10.1038/srep43378. View

15.

Navab R, Strumpf D, Bandarchi B, Zhu C, Pintilie M, Ramnarine V . Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci U S A. 2011; 108(17):7160-5. PMC: 3084093. DOI: 10.1073/pnas.1014506108. View

16.

Gorchs L, Moro C, Bankhead P, Kern K, Sadeak I, Meng Q . Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4 and CD8 T-Cells. Front Immunol. 2019; 10:847. PMC: 6491453. DOI: 10.3389/fimmu.2019.00847. View

17.

Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

18.

Edelman M, Watson D, Wang X, Morrison C, Kratzke R, Jewell S . Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. J Clin Oncol. 2008; 26(6):848-55. DOI: 10.1200/JCO.2007.13.8081. View

19.

Aran D, Sirota M, Butte A . Systematic pan-cancer analysis of tumour purity. Nat Commun. 2015; 6:8971. PMC: 4671203. DOI: 10.1038/ncomms9971. View

20.

Su S, Chen J, Yao H, Liu J, Yu S, Lao L . CD10GPR77 Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018; 172(4):841-856.e16. DOI: 10.1016/j.cell.2018.01.009. View